|
ABOUT COMPANY
Heron Therapeutics, Inc., a biotechnology company, is dedicated to developing treatments to address unmet medical needs. The company is headquartered in San Diego, California.
|
EARNINGS
Gross Profit (TTM): -120884000
Market Capitalization: 1013234000
Operating Margin (TTM): -2.549
PE Ratio: None
PEG Ratio: -0.18
Profit Margin: -2.646
Revenue Per Share (TTM): 0.901
Revenue (TTM): 86296000
Quarterly Earnings Growth YOY: 0
Quarterly Revenue Growth YOY: 0.164
Trailing PE: -
|
DIVIDENDS
Diluted EPS (TTM): -2.385
Dividend Date: None
Dividend Per Share: None
Dividend Yield: 0%
EBITDA: -205512000
ExDividend Date: None
Forward Annual Dividend Rate:
Forward Annual Dividend Yield:
|